Regulatory effects of black tea on gut microbiota and inflammation in ulcerative colitis

  • XIE Qiurong ,
  • HE Shuyu ,
  • LIN Jiyan ,
  • YE Yuehong ,
  • LI Jiapeng
Expand
  • 1(Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China)
    2(The Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China)
    3(College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China)
    4(Department of Physical Education, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China)

Received date: 2025-11-24

  Revised date: 2026-01-21

  Online published: 2026-06-24

Abstract

Black tea, a widely consumed beverage, has garnered increasing attention for its potential anti-inflammatory and gut health regulatory properties.This study aimed to investigate the protective effect of black tea against dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) in mice and its underlying mechanism involving the modulation of gut microbiota.C57BL/6 mice were randomly divided into a control group, a DSS-induced model group, a black tea treatment group [450 mg/(kg·d)], and a positive control mesalazine group [20 mg/(kg·d)].A chronic UC model was established using 2% (mass fraction) DSS solution, followed by the respective treatments.The results showed that, compared with the model group, black tea treatment significantly alleviated histopathological damage in colon tissue and inhibited the expression of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α (P<0.05).Analysis of gut microbiota by 16S rRNA sequencing revealed that black tea treatment significantly restored microbial richness (Chao1 and ACE indices, P<0.05), reduced the relative abundance of harmful bacteria such as Proteobacteria, Gammaproteobacteria, Burkholderiales, Sutterellaceae, Parasutterella, Bacteroides acidifaciens, and Desulfovibrio (P<0.05), while increasing the abundance of beneficial bacteria such as Muribaculaceae and Blautia (P<0.05).Further functional prediction indicated that black tea treatment up-regulated beneficial metabolic pathways related to carbohydrate derivative synthesis and coenzyme regeneration, such as PWY-7315, PWY-6396, METH-ACETATE-PWY, and NAD-BIOSYNTHESIS-Ⅱ, while down-regulating harmful pathways associated with bacterial drug resistance and oxidative stress, such as P23-PWY, P461-PWY, HEMESYN2-PWY, and PWY-7377) (P<0.05).In conclusion, black tea effectively alleviated DSS-induced ulcerative colitis in mice, and its mechanism is closely related to multi-dimensionally remodeling of gut microbiota structure, restoration of microecological balance, and regulation of microbial functional metabolism, thereby synergistically exerting anti-inflammatory and intestinal mucosal protective effects.This study provides experimental evidence for black tea as a potential microecological modulator to assist in managing gut health.

Cite this article

XIE Qiurong , HE Shuyu , LIN Jiyan , YE Yuehong , LI Jiapeng . Regulatory effects of black tea on gut microbiota and inflammation in ulcerative colitis[J]. Food and Fermentation Industries, 2026 , 52(11) : 92 -100 . DOI: 10.13995/j.cnki.11-1802/ts.045271

References

[1] KAPLAN G G, WINDSOR J W.The four epidemiological stages in the global evolution of inflammatory bowel disease[J].Nature Reviews Gastroenterology & Hepatology, 2021, 18(1):56-66.
[2] LLOYD-PRICE J, ARZE C, ANANTHAKRISHNAN A N, et al.Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases[J].Nature, 2019, 569(7758):655-662.
[3] LAVELLE A, SOKOL H.Gut microbiota-derived metabolites as key actors in inflammatory bowel disease[J].Nature Reviews Gastroenterology & Hepatology, 2020, 17(4):223-237.
[4] YU S Y, ZHU X, ZHAO X Y, et al.Improvement of chronic metabolic inflammation and regulation of gut homeostasis:Tea as a potential therapy[J].Pharmacology & Therapeutics, 2025, 269:108828.
[5] TANG G Y, MENG X, GAN R Y, et al.Health functions and related molecular mechanisms of tea components:An update review[J].International Journal of Molecular Sciences, 2019, 20(24):6196.
[6] 曾鸿哲, 方雯雯, 周方, 等.陈年武夷岩茶对葡聚糖硫酸钠诱导小鼠结肠炎的缓解作用及肠道菌群的影响[J].食品科学, 2023, 44(13):67-78.
ZENG H Z, FANG W W, ZHOU F, et al.Effect of aged Wuyi rock tea on relieving dextran sulfate sodium-induced colitis and regulating the gut microbiota in mice[J].Food Science, 2023, 44(13):67-78.
[7] LIU L Y, CHEN Y Q, HAN Y Y, et al.Qing Hua Chang Yin ameliorates chronic colitis in mice by inhibiting PERK-ATF4-CHOP pathway of ER stress and the NF-κB signalling pathway[J].Pharmaceutical Biology, 2024, 62(1):607-620.
[8] NI J, WU G D, ALBENBERG L, et al.Gut microbiota and IBD:Causation or correlation[J].Nature Reviews Gastroenterology & Hepatology, 2017, 14(10):573-584.
[9] WIRTZ S, POPP V, KINDERMANN M, et al.Chemically induced mouse models of acute and chronic intestinal inflammation[J].Nature Protocols, 2017, 12(7):1295-1309.
[10] CHANG J T.Pathophysiology of inflammatory bowel diseases[J].The New England Journal of Medicine, 2020, 383(27):2652-2664.
[11] NI J H, ZHANG L J, FENG G Z, et al.Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9/STIM1-mediated ferroptosis[J].Pharmacological Research, 2024, 202:107128.
[12] HAO W, CHEN Z J, YUAN Q, et al.Ginger polysaccharides relieve ulcerative colitis via maintaining intestinal barrier integrity and gut microbiota modulation[J].International Journal of Biological Macromolecules, 2022, 219:730-739.
[13] SONG Y A, PARK Y L, YOON S H, et al.Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells[J].Inflammation Research, 2011, 60(5):493-500.
[14] SHI Y X, GUO S S, ZHOU J H, et al.Black tea preserves intestinal homeostasis through balancing barriers and microbiota in mice[J].Frontiers in Nutrition, 2024, 11:1367047.
[15] WANG X Z, LIU Y N, WU Z F, et al.Tea polyphenols:A natural antioxidant regulates gut flora to protect the intestinal mucosa and prevent chronic diseases[J].Antioxidants, 2022, 11(2):253.
[16] NEURATH M F.Targeting immune cell circuits and trafficking in inflammatory bowel disease[J].Nature Immunology, 2019, 20(8):970-979.
[17] RAINE T, BONOVAS S, BURISCH J, et al.ECCO guidelines on therapeutics in ulcerative colitis:Medical treatment[J].Journal of Crohn’s and Colitis, 2022, 16(1):2-17.
[18] PITTAYANON R, LAU J T, LEONTIADIS G I, et al.Differences in gut microbiota in patients with vs without inflammatory bowel diseases:A systematic review[J].Gastroenterology, 2020, 158(4):930-946.e1.
[19] SHIN N R, WHON T W, BAE J W.Proteobacteria:Microbial signature of dysbiosis in gut microbiota[J].Trends in Biotechnology, 2015, 33(9):496-503.
[20] YILMAZ B, LI H.Gut microbiota and iron:The crucial actors in health and disease[J].Pharmaceuticals, 2018, 11(4):98.
[21] LAGKOUVARDOS I, LESKER T R, HITCH T C A, et al.Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family[J].Microbiome, 2019, 7(1):28.
[22] LIU X M, MAO B Y, GU J Y, et al.Blautia:A new functional genus with potential probiotic properties[J].Gut Microbes, 2021, 13(1):1875796.
[23] CAI J, SUN L L, GONZALEZ F J.Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis[J].Cell Host Microbe, 2022, 30(3):289-300.
[24] ZHANG Y N, TU S Y, JI X W, et al.Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway[J].Nature Communications, 2024, 15:1333.
[25] 张鑫迪, 杜艳, 牛敏.耐碳青霉烯类肺炎克雷伯菌脂多糖修饰相关的多黏菌素耐药机制研究[J].中华微生物学和免疫学杂志, 2023, 43(6):442-450.
ZHANG X D, DU Y, NIU M.Mechanism of polymyxin resistance related to lipopolysaccharide modification in carbapenem-resistant Klebsiella pneumoniae[J].Chinese Journal of Microbiology and Immunology, 2023, 43(6):442-450.
[26] BRINCK J E, SINHA A K, LAURSEN M F, et al.Intestinal pH:A major driver of human gut microbiota composition and metabolism[J].Nature Reviews Gastroenterology & Hepatology, 2025, 22(9):639-656.
[27] NIÑO-NARVIÓN J, ROJO-LÓPEZ M I, MARTINEZ-SANTOS P, et al.NAD+ precursors and intestinal inflammation:therapeutic insights involving gut microbiota[J].Nutrients, 2023, 15(13):2992.
Outlines

/

〈 〉